Cargando…
Current and Potential New Targets in Systemic Sclerosis Therapy: a New Hope
PURPOSE OF REVIEW: Systemic sclerosis (SSc) is an autoimmune connective tissue disease in which there is an activation of fibroblast to a myofibroblast that secretes huge amounts of extracellular matrix. Currently, no treatment exists that modifies the fibrosis elements and new therapeutic targets a...
Autores principales: | Hinchcliff, Monique, O’Reilly, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305248/ https://www.ncbi.nlm.nih.gov/pubmed/32562016 http://dx.doi.org/10.1007/s11926-020-00918-3 |
Ejemplares similares
-
Cellular Therapies in Systemic Sclerosis: Recent Progress
por: van Rhijn-Brouwer, Femke C. C., et al.
Publicado: (2016) -
Genetics of Systemic Sclerosis: An Update
por: Broen, Jasper C. A., et al.
Publicado: (2011) -
Interfacial Adipose Tissue in Systemic Sclerosis
por: Kruglikov, Ilja L.
Publicado: (2017) -
Recent Advances in the Genetics of Systemic Sclerosis: Toward Biological and Clinical Significance
por: Korman, Benjamin D., et al.
Publicado: (2015) -
Dissecting Fibroblast Heterogeneity in Health and Fibrotic Disease
por: Shaw, Tanya J, et al.
Publicado: (2020)